Capha Pharmaceuticals Inc. announced earnings results for the third quarter ended September 30, 2019. For the third quarter, the company announced net loss was CAD 16,448 compared to CAD 12,926 a year ago. For the nine months, net loss was CAD 49,200 compared to CAD 86,702 a year ago.